Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 114201-114250 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT02456090
PaTH Clinical Data Research Network (CDRN) Study of Healthy Lifestyles and Health Care
N/A
Active, not recruiting
1,500 participants
Started: May 31, 2015 · Completed: Jul 31, 2030
1 condition
5 sponsors
5 locations
NCT03214263
Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases
N/A
Recruiting
20,000 participants
Started: May 31, 2015 · Completed: Dec 31, 2024
5 conditions
13 sponsors
11 locations
NCT02413970
Inspire® Post-Approval Study / Protocol Number 2014-001
NA
Active, not recruiting
127 participants
Started: May 31, 2015 · Completed: Jun 30, 2025
1 condition
1 sponsor
14 locations
NCT02368041
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
N/A
Recruiting
130 participants
Started: May 31, 2015 · Completed: May 10, 2026
1 condition
1 sponsor
1 location
NCT05753124
Effect of Obesity, Diabetes and Bariatric Surgery on Pregnancy Outcomes
N/A
Recruiting
700 participants
Started: May 31, 2015 · Completed: Oct 31, 2027
5 conditions
1 sponsor
1 location
NCT02793999
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
N/A
Recruiting
125 participants
Started: May 31, 2015 · Completed: May 31, 2027
2 conditions
4 sponsors
3 locations
NCT02508454
The Miami Heart Study at Baptist Health South Florida
N/A
Active, not recruiting
4,000 participants
Started: May 31, 2015 · Completed: Sep 30, 2028
1 condition
3 sponsors
1 location
NCT02461446
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
N/A
Recruiting
170 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
5 conditions
6 sponsors
5 locations
NCT06239142
Understanding Mental Fatigue After Subarachnoid Hemorrhage
N/A
Active, not recruiting
64 participants
Started: May 31, 2015 · Completed: Jun 30, 2024
2 conditions
1 sponsor
0 locations
NCT02252380
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
NA
Active, not recruiting
10 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
9 conditions
1 sponsor
2 locations
NCT02512250
Swiss Hemophilia Registry
N/A
Recruiting
900 participants
Started: May 31, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
19 locations
NCT02450708
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
NA
Active, not recruiting
511 participants
Started: May 31, 2015 · Completed: May 31, 2026
1 condition
9 sponsors
10 locations
NCT02413736
Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST
PHASE3
Active, not recruiting
255 participants
Started: May 31, 2015 · Completed: Jun 30, 2033
1 condition
2 sponsors
1 location
NCT02647177
A Prospective Study To Identify Predictive Biological Markers In Blood And Cyst Fluid Aspirates From Patients With Pancreatic Cyst Lesions
N/A
Recruiting
1,000 participants
Started: May 31, 2015 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
NCT02415413
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
PHASE2
Active, not recruiting
90 participants
Started: May 31, 2015 · Completed: Jun 30, 2027
1 condition
3 sponsors
16 locations
NCT02455505
Identifying Family Members in Need of Support While Caregiving and After Loss
N/A
Active, not recruiting
52 participants
Started: May 31, 2015 · Completed: May 31, 2027
1 condition
4 sponsors
2 locations
NCT02505464
Pregnancies Complicated by Fetal Anomalies
N/A
Recruiting
500 participants
Started: May 31, 2015 · Completed: Apr 30, 2028
2 conditions
2 sponsors
5 locations
NCT02425904
Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders
PHASE2
Active, not recruiting
25 participants
Started: May 31, 2015 · Completed: Jan 31, 2026
1 condition
5 sponsors
15 locations
NCT02422641
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
PHASE2
Recruiting
16 participants
Started: May 31, 2015 · Completed: Jan 31, 2027
2 conditions
2 sponsors
3 locations
NCT02437526
Analytic Treatment Interruption (ATI) to Assess HIV Cure
NA
Enrolling by invitation
10 participants
Started: May 31, 2015 · Completed: May 31, 2035
1 condition
1 sponsor
1 location
NCT02283281
Anesthetic Premedication With a Cannabis Extract (Cannapremed)
PHASE2/PHASE3
Recruiting
200 participants
Started: May 31, 2015 · Completed: Dec 31, 2024
3 conditions
2 sponsors
1 location
NCT02674217
Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells
NA
Enrolling by invitation
1,000 participants
Started: May 31, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
0 locations
NCT02506361
Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer
N/A
Recruiting
800 participants
Started: May 31, 2015 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT02445885
Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
NA
Recruiting
150 participants
Started: May 31, 2015 · Completed: Mar 1, 2039
2 conditions
1 sponsor
1 location
NCT04484064
Optimization of the Targeted Anticancer Therapies
NA
Recruiting
500 participants
Started: May 31, 2015 · Completed: Dec 31, 2030
1 condition
3 sponsors
1 location
NCT02454543
Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases
NA
Active, not recruiting
452 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT02447874
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
PHASE1/PHASE2
Recruiting
21 participants
Started: May 31, 2015 · Completed: Jul 31, 2026
1 condition
3 sponsors
2 locations
NCT01704586
I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer
NA
Recruiting
340 participants
Started: May 31, 2015 · Completed: Nov 30, 2025
1 condition
2 sponsors
2 locations
NCT02347722
Biomarkers to Classify Heart Failure
N/A
Active, not recruiting
511 participants
Started: May 31, 2015 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT02394834
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
N/A
Active, not recruiting
757 participants
Started: May 29, 2015 · Completed: Mar 31, 2026
1 condition
1 sponsor
151 locations
NCT02311933
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
PHASE2
Active, not recruiting
81 participants
Started: May 28, 2015 · Completed: Feb 4, 2026
6 conditions
1 sponsor
563 locations
NCT02393625
Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer
PHASE1
Active, not recruiting
57 participants
Started: May 27, 2015 · Completed: Apr 9, 2026
1 condition
1 sponsor
12 locations
NCT02400190
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NA
Active, not recruiting
202 participants
Started: May 27, 2015 · Completed: May 31, 2026
1 condition
12 sponsors
13 locations
NCT05908123
Exploring the Nature, Assessment and Treatment of Stuttering
NA
Recruiting
3,000 participants
Started: May 22, 2015 · Completed: May 22, 2035
4 conditions
1 sponsor
1 location
NCT02474160
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
N/A
Recruiting
5,000 participants
Started: May 19, 2015 · Completed: May 4, 2026
4 conditions
2 sponsors
140 locations
NCT02257528
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
PHASE2
Active, not recruiting
26 participants
Started: May 18, 2015 · Completed: Mar 17, 2026
6 conditions
2 sponsors
333 locations
NCT02208362
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
PHASE1
Active, not recruiting
65 participants
Started: May 18, 2015 · Completed: Jun 8, 2026
8 conditions
3 sponsors
1 location
NCT03209791
Ethanol Induces Skeletal Muscle Autophagy
N/A
Recruiting
40 participants
Started: May 18, 2015 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04565366
Transforming Research and Clinical Knowledge in Spinal Cord Injury
N/A
Enrolling by invitation
726 participants
Started: May 14, 2015 · Completed: Dec 1, 2028
1 condition
4 sponsors
5 locations
NCT02314169
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
PHASE2
Active, not recruiting
37 participants
Started: May 13, 2015 · Completed: Mar 21, 2026
3 conditions
1 sponsor
56 locations
NCT02383342
Pain Predict Genetics
N/A
Recruiting
10,000 participants
Started: May 12, 2015 · Completed: Mar 31, 2029
2 conditions
1 sponsor
1 location
NCT02652078
Shockwave Therapy in Lower Limb Intermittent Calf Claudication
NA
Active, not recruiting
138 participants
Started: May 11, 2015 · Completed: Feb 1, 2030
1 condition
2 sponsors
1 location
NCT02390518
Stereotactic Radiosurgery Dose Escalation for Brain Metastases
PHASE1
Recruiting
50 participants
Started: May 7, 2015 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT02438722
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
PHASE2/PHASE3
Active, not recruiting
174 participants
Started: May 7, 2015 · Completed: Nov 15, 2025
2 conditions
2 sponsors
638 locations
NCT04254731
Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals
PHASE4
Active, not recruiting
10 participants
Started: May 7, 2015 · Completed: Jul 30, 2024
3 conditions
1 sponsor
3 locations
NCT02411448
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)
PHASE3
Active, not recruiting
545 participants
Started: May 6, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
106 locations
NCT05780502
Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Lower Extremity Musculoskeletal Disorders
N/A
Recruiting
370 participants
Started: May 6, 2015 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT02438904
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
NA
Recruiting
200 participants
Started: May 6, 2015 · Completed: May 1, 2027
1 condition
1 sponsor
1 location
NCT02449421
Sustaining and Improving Clinicians' Use of Evidence-Based Psychotherapy (EBP) for PTSD
NA
Active, not recruiting
90 participants
Started: May 6, 2015 · Completed: Jun 30, 2024
1 condition
6 sponsors
3 locations
NCT02435810
Inflammatory and Infectious Diseases of the Nervous System
N/A
Recruiting
1,000 participants
Started: May 6, 2015 · Completed: Nov 29, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
2282
2283
2284
2285
2286
2287
2288
More pages
2369
Next